Holds a game-changing platform exploiting protein-conformation dynamics to discover next generation GPCR drugs devoid of on-target side effects once thought to be unavoidable.
Active Portfolio Company
www.mebiasdiscovery.com
Active Portfolio Company
www.mebiasdiscovery.com
Location: United States, Pennsylvania, Philadelphia
Employees: 11-50
Total raised: $3.5M
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | BioAdvance | bioadvance... |
| - | Westfield ... | westfieldb... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.10.2019 | - | $3.5M | - |
Mentions in press and media 2
| Date | Title | Description |
| 14.10.2019 | Mebias Discovery Closes $3.5M Funding Round | Mebias Discovery, a Philadelphia, PA-based leader in the field of drug discovery targeting G-protein coupled receptors (GPCR), closed a $3.5M funding round. The round was led by Viva Biotech Ltd. and Sprout BioVentures. The company intends ... |
| - | Mebias Discovery | “Home - Mebias-Discovery” |